Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device aims to curb dangerous bleeding in heart surgery patients on blood thinners

NCT ID NCT07284199

First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study tests a device called CA330 that filters blood during heart surgery to reduce severe bleeding. It is for 120 adults who take blood thinners and need urgent heart surgery. Participants are randomly assigned to receive the device or standard care, and researchers track bleeding, transfusions, and recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CABG are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100029, China

Conditions

Explore the condition pages connected to this study.